TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | -5 | -17 | -11 | 4 | -57 | -14 |
| P | %wins | 100 | 33 | 0 | 33 | 33 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/3/12 13:16 | 6/29/12 | APPY | Aspenbio Pharma, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Merson Michael R | CO | D | P | 2 | 1.92 | 0 | 1 | 556 | 1 | D | -94 | -91 | -67 | -55 | -47 | -33 | -5 | -3 | 1 | 3 | -16 | 36 | 38 | -28 | |
8/11/09 19:10 | 8/6/09 | APPY | Aspenbio Pharma, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Merson Michael R | MD | D | P.d | 3 | 2.85 | 0 | 1 | 26 | 5 | D | -46 | -52 | 63 | 67 | 13 | 32 | -1 | 5 | 0 | -8 | -13 | -30 | -7 | -67 | |
8/5/09 18:31 | 7/31/09 | APPY | Aspenbio Pharma, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Merson Michael R | MD | D | P.d | 2 | 2.80 | 0 | 1 | 23 | 4 | D | -49 | -53 | 88 | 53 | 12 | 36 | 17 | -6 | 4 | -9 | -22 | -38 | -19 | -77 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |